CD8A and breast carcinoma: It is necessary to refine the indicators that allow for the identification of CD8+ T-cell phenotypes and to explore the regulatory mechanisms of CD8+ T cells, especially in other breast cancer subtypes except for TNBC (11, 13, 14).